• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于深入强制降解分析聚(ADP-核糖)聚合酶(PARP)抑制剂奥拉帕利、芦卡帕利和尼拉帕利的大规模化学分析平台

MassChemSite for In-Depth Forced Degradation Analysis of PARP Inhibitors Olaparib, Rucaparib, and Niraparib.

作者信息

Bonciarelli Stefano, Desantis Jenny, Cerquiglini Simone, Goracci Laura

机构信息

Department of Chemistry, Biology and Biotechnology, University of Perugia, Via Elce di Sotto 8, 06123Perugia, Italy.

出版信息

ACS Omega. 2023 Feb 9;8(7):7005-7016. doi: 10.1021/acsomega.2c07815. eCollection 2023 Feb 21.

DOI:10.1021/acsomega.2c07815
PMID:36844573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9948214/
Abstract

Drugs must satisfy several protocols and tests before being approved for the market. Among them, forced degradation studies aim to evaluate drug stability under stressful conditions in order to predict the formation of harmful degradation products (DPs). Recent advances in LC-MS instrumentation have facilitated the structure elucidation of degradants, although a comprehensive data analysis still represents a bottle-neck due to the massive amount of data that can be easily generated. MassChemSite has been recently described as a promising informatics solution for LC-MS/MS and UV data analysis of forced degradation experiments and for the automated structural identification of DPs. Here, we applied MassChemSite to investigate the forced degradation of three poly(ADP-ribose) polymerase inhibitors (olaparib, rucaparib, and niraparib) under basic, acidic, neutral, and oxidative stress conditions. Samples were analyzed by UHPLC with online DAD coupled to high-resolution mass spectrometry. The kinetic evolution of the reactions and the influence of solvent on the degradation process were also assessed. Our investigation confirmed the formation of three DPs of olaparib and the wide degradation of the drug under the basic condition. Intriguingly, base-catalyzed hydrolysis of olaparib was greater when the content of aprotic-dipolar solvent in the mixture decreased. For the other two compounds, whose stability has been much less studied previously, six new degradants of rucaparib were identified under oxidative degradation, while niraparib emerged as stable under all stress conditions tested.

摘要

药物在获得市场批准之前必须满足多项协议和测试。其中,强制降解研究旨在评估药物在应激条件下的稳定性,以预测有害降解产物(DPs)的形成。液相色谱 - 质谱联用仪器的最新进展有助于降解产物的结构解析,尽管由于能够轻松生成大量数据,全面的数据分析仍然是一个瓶颈。MassChemSite最近被描述为一种有前景的信息学解决方案,用于强制降解实验的液相色谱 - 串联质谱和紫外数据分析以及降解产物的自动结构鉴定。在此,我们应用MassChemSite研究三种聚(ADP - 核糖)聚合酶抑制剂(奥拉帕利、卢卡帕利和尼拉帕利)在碱性、酸性、中性和氧化应激条件下的强制降解。通过超高效液相色谱与在线二极管阵列检测器联用高分辨率质谱对样品进行分析。还评估了反应的动力学演变以及溶剂对降解过程的影响。我们的研究证实了奥拉帕利三种降解产物的形成以及该药物在碱性条件下的广泛降解。有趣的是,当混合物中非质子偶极溶剂的含量降低时,奥拉帕利的碱催化水解作用更强。对于另外两种之前稳定性研究较少的化合物,在氧化降解条件下鉴定出卢卡帕利的六种新降解产物,而尼拉帕利在所有测试的应激条件下均表现稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/440853d9684a/ao2c07815_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/32ddbba9e0c4/ao2c07815_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/ca8b9e6463ce/ao2c07815_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/4c429158afe0/ao2c07815_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/f8527ae4bc4a/ao2c07815_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/96ef745d5151/ao2c07815_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/ae44094b0e11/ao2c07815_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/f0d6aa6d1851/ao2c07815_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/440853d9684a/ao2c07815_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/32ddbba9e0c4/ao2c07815_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/ca8b9e6463ce/ao2c07815_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/4c429158afe0/ao2c07815_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/f8527ae4bc4a/ao2c07815_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/96ef745d5151/ao2c07815_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/ae44094b0e11/ao2c07815_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/f0d6aa6d1851/ao2c07815_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c031/9948214/440853d9684a/ao2c07815_0009.jpg

相似文献

1
MassChemSite for In-Depth Forced Degradation Analysis of PARP Inhibitors Olaparib, Rucaparib, and Niraparib.用于深入强制降解分析聚(ADP-核糖)聚合酶(PARP)抑制剂奥拉帕利、芦卡帕利和尼拉帕利的大规模化学分析平台
ACS Omega. 2023 Feb 9;8(7):7005-7016. doi: 10.1021/acsomega.2c07815. eCollection 2023 Feb 21.
2
Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.奥拉帕利的稳定性指示分析方法验证:LC-ESI-Q-TOF-MS/MS 和 NMR 研究用于鉴定其新的水解和氧化强制降解产物。
J Pharm Biomed Anal. 2018 Oct 25;160:89-98. doi: 10.1016/j.jpba.2018.07.017. Epub 2018 Jul 18.
3
Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data.聚(ADP-核糖)聚合酶抑制剂在卵巢癌中的应用:一项美国医疗保健索赔数据的回顾性队列研究。
Adv Ther. 2022 Jan;39(1):328-345. doi: 10.1007/s12325-021-01959-5. Epub 2021 Nov 2.
4
Comparative Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Ovarian Cancer: A Systematic Review and Network Meta-Analysis.聚(ADP - 核糖)聚合酶抑制剂在卵巢癌患者中的疗效和安全性比较:一项系统评价和网状荟萃分析
Front Oncol. 2022 Jun 8;12:815265. doi: 10.3389/fonc.2022.815265. eCollection 2022.
5
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.用于定量测定人血浆和干血斑中PARP抑制剂奥拉帕利、卢卡帕利和尼拉帕利的LC-MS/MS方法:治疗药物监测的方法开发、验证及临床验证
Pharmaceutics. 2023 May 18;15(5):1524. doi: 10.3390/pharmaceutics15051524.
6
Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA).综合运用色谱(LC-UV 和 UHPLC-DAD-MS)和光谱(中红外和近红外与 PCA)技术深入研究重要抗糖尿病药物维格列汀的化学稳定性
Molecules. 2021 Sep 16;26(18):5632. doi: 10.3390/molecules26185632.
7
Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.采用超高效液相色谱-四极杆飞行时间质谱联用(UPLC-Q-TOF/MS/MS)和 NMR 技术鉴定和表征盐酸舍曲林的强制降解产物。
J Pharm Biomed Anal. 2022 Nov 30;221:115045. doi: 10.1016/j.jpba.2022.115045. Epub 2022 Sep 13.
8
Automatic Identification of Lansoprazole Degradants under Stress Conditions by LC-HRMS with MassChemSite and WebChembase.利用 LC-HRMS 结合 MassChemSite 和 WebChembase 自动识别兰索拉唑在应激条件下的降解产物。
J Chem Inf Model. 2021 Jun 28;61(6):2706-2719. doi: 10.1021/acs.jcim.1c00226. Epub 2021 Jun 1.
9
Characterization of forced degradation products of clozapine by LC-DAD/ESI-Q-TOF.采用液相色谱-二极管阵列检测器/电喷雾离子化-四极杆飞行时间质谱联用技术对氯氮平的强制降解产物进行表征。
J Pharm Biomed Anal. 2016 Nov 30;131:272-280. doi: 10.1016/j.jpba.2016.09.007. Epub 2016 Sep 4.
10
Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib.BMN 673的立体特异性聚(ADP-核糖)聚合酶捕获及其与奥拉帕尼和卢卡帕尼的比较。
Mol Cancer Ther. 2014 Feb;13(2):433-43. doi: 10.1158/1535-7163.MCT-13-0803. Epub 2013 Dec 19.

本文引用的文献

1
Degradation kinetics and characterization of major degradants of binimetinib employing liquid chromatography-high resolution mass spectrometry.使用液相色谱-高分辨率质谱法研究比美替尼主要降解产物的降解动力学及特性
J Pharm Biomed Anal. 2022 Jun 5;215:114753. doi: 10.1016/j.jpba.2022.114753. Epub 2022 Apr 5.
2
Development of the Validated Stability-Indicating Method for the Determination of Vortioxetine in Bulk and Pharmaceutical Formulation by HPLC-DAD, Stress Degradation Kinetics Studies and Detection of Degradation Products by LC-ESI-QTOF-MS.建立 HPLC-DAD 测定文拉法辛原料药及其制剂含量的专属性方法,对其进行稳定性研究并采用 LC-ESI-QTOF-MS 检测降解产物。
Molecules. 2022 Mar 14;27(6):1883. doi: 10.3390/molecules27061883.
3
Automatic Identification of Lansoprazole Degradants under Stress Conditions by LC-HRMS with MassChemSite and WebChembase.利用 LC-HRMS 结合 MassChemSite 和 WebChembase 自动识别兰索拉唑在应激条件下的降解产物。
J Chem Inf Model. 2021 Jun 28;61(6):2706-2719. doi: 10.1021/acs.jcim.1c00226. Epub 2021 Jun 1.
4
Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy.PARP 抑制剂在卵巢癌治疗中的差异:作用机制、药理学、安全性和疗效。
Int J Mol Sci. 2021 Apr 19;22(8):4203. doi: 10.3390/ijms22084203.
5
Chemometrics Approaches in Forced Degradation Studies of Pharmaceutical Drugs.化学计量学方法在药物强制降解研究中的应用。
Molecules. 2019 Oct 22;24(20):3804. doi: 10.3390/molecules24203804.
6
Degradation studies of dimethachlor in soils and water by UHPLC-HRMS: putative elucidation of unknown metabolites.超高效液相色谱-高分辨质谱法研究二甲戊灵在土壤和水中的降解:未知代谢物的推测解析。
Pest Manag Sci. 2020 Feb;76(2):721-729. doi: 10.1002/ps.5570. Epub 2019 Aug 27.
7
Multi-Steps Fragmentation-Ion Trap Mass Spectrometry Coupled to Liquid Chromatography Diode Array System for Investigation of Olaparib Related Substances.采用液相色谱二极管阵列系统与多步碎裂-离子阱质谱联用技术研究奥拉帕尼相关物质。
Molecules. 2019 Feb 27;24(5):843. doi: 10.3390/molecules24050843.
8
Identification and structural characterization of hydrolytic degradation products of alvimopan by LC/QTOF/MS/MS and NMR studies.通过 LC/QTOF/MS/MS 和 NMR 研究鉴定和结构表征阿维莫潘的水解降解产物。
J Pharm Biomed Anal. 2019 Feb 20;165:399-409. doi: 10.1016/j.jpba.2018.12.035. Epub 2018 Dec 21.
9
Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.奥拉帕利的稳定性指示分析方法验证:LC-ESI-Q-TOF-MS/MS 和 NMR 研究用于鉴定其新的水解和氧化强制降解产物。
J Pharm Biomed Anal. 2018 Oct 25;160:89-98. doi: 10.1016/j.jpba.2018.07.017. Epub 2018 Jul 18.
10
Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: Toxicity evaluation of degradation products.使用液相色谱/四极杆飞行时间电喷雾串联质谱(LC/Q-TOF-ESI-MS/MS)和核磁共振(NMR)对琥珀酸舒马曲坦的应激降解产物进行鉴定和表征:降解产物的毒性评估
J Mass Spectrom. 2018 Oct;53(10):963-975. doi: 10.1002/jms.4266. Epub 2018 Aug 15.